Skip to main content

Advertisement

Table 3 Associations of single acylcarnitines and combined indexes with baseline eGFR

From: Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy

Name Association with baseline eGFR
β SE P
Free carnitine (C0) −0.21 0.11 0.110108011
Acetylcarnitine (C2) −0.36 0.1 0.001989281
Butyrylcarnitine (C4) −0.63 0.08 7.42E-10
semi Tiglyl-carnitine (C5:1) −0.56 0.09 4.10E-07
Valerylcarnitine (C5) −0.37 0.11 0.002867891
semi Octanenoylcarnitine (C8:1) −0.46 0.1 0.00012474
Octanoylcarnitine (C8) −0.13 0.11 0.333735122
Malonylcarnitine (C3DC) −0.41 0.1 0.000543281
C10:1 −0.32 0.11 0.011733593
Decanoylcarnitine (C10) −0.12 0.11 0.336089636
C5DC −0.65 0.08 3.01E-10
semi Dodecenoylcarnitine (C12:1) −0.25 0.1 0.041281611
Dodecanoylcarnitine (C12) −0.19 0.11 0.147639204
semi 3-Hydroxydodecanoylcarnitne (C12OH) −0.27 0.11 0.03221931
C14:1 −0.16 0.11 0.227662143
Myristoylcarnitine (C14) −0.23 0.1 0.061749229
semi (C16:2) −0.26 0.1 0.035592205
semi Palmitoleylcarnitine (C16:1) − 0.25 0.1 0.04354928
Palmitoylcarnitine (C16) −0.16 0.11 0.227662143
semi Sebacylcarnitine (C10DC) −0.12 0.11 0.366303947
semi Linoleylcarnitine(C18:2) −0.06 0.11 0.641083979
semi Oleylcarnitine (C18:1) −0.06 0.11 0.641083979
semi Stearoylcarnitine (C18) −0.11 0.11 0.410468226
semi C12DC −0.12 0.11 0.353100378
semi 3-Hydroxylinoleyl(C18:2OH) 0.05 0.11 0.682991111
semi 3-Hydroxystearoylcarnitine (C18OH) −0.08 0.11 0.53159956
semi Arachidoylcarnitine (C20) −0.13 0.11 0.333735122
Short-chain Acylcarnitine −0.13 0.05 0.028647383
Medium-chain Acylcarnitine −7.66 1.88 0.000543281
Long-chain Acylcarnitine −0.19 0.77 0.800766318
  1. β effect size, SE standard error
  2. Model was adjusted for age and sex
  3. P value was adjusted with BH correction